Skip to main content
. 2017 Mar 22;7:45049. doi: 10.1038/srep45049

Figure 3. Distributions of the expressions and activities of TG1 and TG2 in fibrotic livers.

Figure 3

Each liver section was subjected to the immunohistochemistry and in situ TG activity staining on the indicated days after BDL surgery (n = 3 mice). (A) Immunostaining was performed using polyclonal anti-mouse TG1 and TG2 antibodies, and rabbit NI-IgG as the negative control. Bar = 100 μm. (B) The in situ activities of TG1 and TG2 were visualized using FITC-labeled substrate peptides (pepK5 and pepT26, respectively). Mutant peptides (pepK5QN and pepT26QN) were used as the negative control. Bar = 50 μm.